Research ArticleCancer

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

See allHide authors and affiliations

Science Translational Medicine  14 Mar 2018:
Vol. 10, Issue 432, eaag0945
DOI: 10.1126/scitranslmed.aag0945
PDF Container

Navigate This Article